TMEM119 and myeloid sarcoma: Of note, comparing the EP2+ versus EP2− cells within the Iba1+ population in MS lesion IHC revealed an increased intensity of the homeostatic microglia marker TMEM119 in EP2+ cells (p = 0.0699) (Fig. S5).